Background: Adherence to treatment is a crucial factor in preventing the progression of coronary heart disease. More evidence of the predictors of long-term adherence is needed. Aims: The purpose of this study was to identify the predictive factors of adherence to treatment six years after percutaneous coronary intervention. Methods: Baseline data (n=416) was collected in 2013 and follow-up data in 2019 (n=169) at two university hospitals and three central hospitals in Finland. The self-reported Adherence of Patients with Chronic Disease Instrument was used. Data were analysed using descriptive statistics and binary logistic regression analysis. Results: The respondents reported higher adherence to a healthy lifestyle six years after percutaneous coronary intervention in comparison to four months post-percutaneous coronary intervention; adherence was seen in their healthy behaviour, such as decreased smoking and reduced alcohol consumption. Participating in regular follow-up control predicted adherence. Support from next of kin predicted physical activity and normal cholesterol levels; this outcome was associated with close relationships, which also predicted willingness to be responsible for treatment adherence. Women perceived lower support from nurses and physicians, and they had more fear of complications. Fear was more common among respondents with a longer duration of coronary heart disease. Physical activity and male gender were associated with perceived results of care. Conclusion: Support from next of kin, nurses and physicians, results of care, responsibility, fear of complication and continuum of care predicted adherence to treatment in long term. These issues should be emphasised among women, patients without a close relationship, physically inactive and those with a longer duration of coronary heart disease.
Introduction
Ageing populations and increasing rates of survival following acute coronary syndrome (ACS) have resulted in large numbers of people living with cardiovascular disease (CVD). 1, 2 Adherence to treatment is a key factor in preventing the progression of coronary heart disease (CHD), which remains a leading cause of death and disability in adults worldwide, despite the enhanced prognoses of cardiac patients over the past several decades. 3 According to the theory of adherence of people with chronic disease, adherence is a patient's active, goal-oriented self-management of his/her health status as required by collaboration with healthcare professionals. 4 This theory has been tested and confirmed to be suitable for evaluating post-percutaneous coronary intervention (PCI) patients' adherence to treatment. 5 Adherence to treatment includes adherence to medication and a healthy lifestyle, which are predicted by a patient's sense of responsibility, cooperation with healthcare professionals, sense of normality, motivation, results of care, fear of complications and support from family, nurses and physicians. [5] [6] [7] [8] Adherence to treatment is challenging, although the effects on long-term outcomes are undeniable. Smoking cessation halves the risk of mortality, 9 and increased physical activity 10 and recommended diet 11 reduces that risk by almost one-third. Additionally, failure to adhere to the prescribed medication regimen is associated with poor clinical outcomes, higher readmission rates, increased healthcare costs and increased morbidity and mortality. 12 Despite strong evidence supporting the importance of adherence, non-adherence to treatment represents a common and significant public health problem among post-PCI patients. 13 Approximately 25% of post-PCI patients have at least two modifiable cardiovascular risk factors, 9 but only about 50% of CHD patients make lifestyle changes. 14 Adherence to treatment has been studied in terms of medication and a healthy lifestyle. Many studies have shown that adherence to treatment declines over time. 1 Post-PCI patients' non-adherence to treatment may be intentional or unintentional. Intentional non-adherence is associated with a patient's decision to stop taking or reduce the dosage of their medication; unintentional nonadherence refers to a patient's lack of capacity or cognitive resources, which can lead to non-adherence. 2 However, examples of long-term follow-up data about adherence to treatment and predictors of adherence among post-PCI patients are scarce; thus, efforts must be made to focus on interventions that induce changes in adherence change that can be sustained for long periods of time. To improve patient adherence, it is important to understand why non-adherence occurs. 15 To the best of our knowledge, long-term evidence for adherence and its predictors is scarce. The present study aims to produce new data about long-term adherence based on a followup research design. Toward that end, the study investigated and identified the level of adherence and the predictive factors of adherence to treatment six years after PCI. The study sought to answer the following research questions:
What is the level of adherence in patients with
CHD six years after PCI in comparison to the baseline levels four months after PCI?
2. What are the predictive factors of adherence to treatment in patients with CHD six years after PCI in comparison to the baseline factors four months after PCI?
Methods

Design
This explanatory and descriptive survey is a six-year follow-up study of an initial study that was conducted in five hospitals in 2013 with the aim of identifying the predictive factors of adherence to treatment in patients with CHD after an elective or acute PCI procedure (angioplasty or stent).
Participants
Hospitalised post-PCI patients, ranging in age from 18-75 years, with CHD and no diagnosed memory disorders, were recruited from medical wards at two university hospitals and three central hospitals in Finland in 2013 four months after PCI. At the baseline in 2013, convenience sampling was used to select the study participants. Thus, every patient who was treated with PCI and met the inclusion criteria was invited to participate in the study. A total of 572 patients met the inclusion criteria. Nurses working in the medical wards gave the participants information about the study. The nurses asked the prospective participants for informed consent, and 520 (91%) of the patients agreed to participate. The response rate was 80% (n=416) for the initial study. At baseline, the participants were asked permission to contact them regarding the follow-up study, and 352 (84.6%) of the respondents gave their informed consent. After six years, the final response rate was 48.3% (n=169).
Data collection
Data were collected using questionnaires mailed via the postal service six years after PCI using the same Adherence of People with Chronic Disease Instrument (ACDI) that was employed in the 2013 baseline study; the ACDI is based on the theory of adherence of chronically ill patients developed and tested by Kyngäs. 4 In this follow-up study, the ACDI consisted of 38 items that measured adherence to treatment and the explanatory factors of adherence. Two mean sum variables measured adherence to medication and a healthy lifestyle. These two mean variables were explained by nine mean sum variables: patient responsibility, cooperation, support from next of kin, sense of normality, motivation, results of care, support from nurses, support from physicians and fear of complications. The final questionnaire consisted of 11 mean sum variables and 18 items to measure sociodemographic, health behavioural and disease-specific factors. The details of the ACDI have been presented in previous studies. 5, 8 
Data analysis
Data analysis was conducted using the Statistical Package for Social Sciences software for Windows (SPSS 25) . Missing values were replaced with each item's mean value for the mean sum variables. According to the initial study, 8 the mean sum variables were categorised into two classes. Good adherence with a range <3.5 was combined and assigned a value of one; reduced adherence with values ranging from 3.51 to 5.0 were combined and assigned a value of two. Descriptive statistics (frequencies, percentages, means, standard deviation (SD)) were used to describe the respondents' sociodemographic, health behavioural and disease-specific factors, just as they were in the initial parent study. At the beginning, cross tabulation and the chi-square test were used to identify the relationship between the independent sociodemographic, health behavioural and disease-specific factors and the dependent mean sum variables that explain adherence to treatment (the univariate model; Table 2 ). In cases in which a chi-square test was not appropriate, Fisher's exact test was used. In the second phase, multivariate logistic regression was used to determine which sociodemographic, health behavioural and disease-specific factors predicted adherence to treatment in the standardised model. All statistically significant variables in the univariate model were entered into the multivariate logistic regression using backward stepwise selection. This standardised method facilitated the confirmation of the results of the earlier univariate analysis. Values of p<0.05 were considered to be statistically significant. Differences between the baseline and follow-up groups were analysed using Wilcoxon-test and McNemar's test. In this study, the goodness-of-fit was evaluated using the chi-squared distribution and Nagelkerke R-square values. 16, 17 
Ethical considerations
Approval for the study was obtained from each research centre and the Ethical Review Board of the University Hospital of Kuopio (Ref. 226/2015). In accordance with the Declaration of Helsinki, participants received verbal and written information about the study, which was provided by a registered nurse, before signing the consent forms and being discharged. This information included the purpose and procedures of the study, the voluntary nature of participation and the option to withdraw at any point.
Validity and reliability
In the 2013 initial study, the face validity of the questionnaire was evaluated by three nurses and 15 patients with CHD in a medical ward, and an explanatory factor analysis was conducted to ensure the construct validity of the instrument. The same instrument was used in this follow-up study. Details of the instrument were presented in a previous study. 8 In the initial study, the alpha coefficients ranged from 0.40-0.88, indicating sufficient-to-high internal consistency (0.30-0.92), and the alpha coefficient of the entire scale was 0.80, which indicates high internal consistency. 16 
Results
Sample characteristics
Of the final sample of 169 respondents, most (76.9%, n=130) were male with a mean age of 68.2 years (range: 51-81, SD=7.1); just over three-quarters (76.9%, n=130) were married or in a close personal relationship. Details of the respondents are presented in Table 3 .
Prevalence of good adherence to treatment and explanatory factors of adherence among patients with CHD after PCI
The majority of the respondents (95.9%, n=162) reported a high level of adherence to medication and a healthy lifestyle (91.7%, n=155) six years after PCI ( Table 4 ). The majority of the respondents adhered to blood pressure medication (80.5%, n=136) and cholesterol medication (90.4%, n=150, Table 3 ). Levels of adherence to medication and a healthy lifestyle were higher in the follow-up study in comparison to the 2013 baseline values obtained, four months after PCI; adherence to a healthy lifestyle was statistically significantly higher in the follow-up study than the baseline study (baseline 2013 mean 3.27, 25 th -75 th percentile 2.81-3.75; follow-up 2019 mean 3.40, 25 th -75 th percentile 3.0-3.75; p=0.05).
The predictors of adherence (motivation, patient responsibility, cooperation, sense of normality, fear of complications and support from next of kin, nurses and physicians) did not differ significantly from the 2013 baseline findings, although a different model explained adherence to treatment six years after PCI. In the baseline study, the sense of normality, cooperation and motivation predicted adherence, explaining 28-32% of the model. In this follow-up study, support from next of kin and nurses and results of care were the strongest predictors of adherence to a healthy lifestyle explaining 30-50% of the model.
Sociodemographic, health behavioural and disease-specific factors predicting adherence to treatment
In the follow-up study ( Table 3) , inspection of the respondents' health behaviours confirmed higher levels of adherence to a healthy lifestyle in comparison to the baseline. Results in the follow-up study ( Table 5 ) indicated that the number of respondents that smoked was statistically lower 4%, n=64) . In the 2013 baseline study, one-fourth (23.7%, n=22) of the smokers had stopped smoking after PCI. Additionally, alcohol consumption (based on recommendations of a maximum of two portions at a time) 18 was 61.9 % (n=88) for the follow-up study respondents, which is statistical significantly lower than the baseline finding in which 47.8% (n=171) of the patients followed recommendations regarding alcohol consumption. Additionally (Table 3 ), in 2019, 42.0% (n=71) of the respondents in the follow-up study reported engaging in at least 120 min of moderate levels of physical exercise; in the baseline study, that number was 38.2% (n=158). Instead, respondents consumed vegetables in their diet on average 2.5 decilitre (dl)/day in 2019, and 6.5% (n=11) of the respondents achieved the recommend consumption of 5 dl/day. In comparison, in the 2013 study, 8.9% (n=37) of the respondents consumed vegetables at least 5 dl/day. While the differences are not statistically significant, they are clinically noteworthy.
Multivariate logistic regression ( Table 6 ) was conducted to determine whether sociodemographic, health behavioural and disease-specific factors were predictors of adherence to treatment. The results indicate that support from next of kin was the strongest predictor of adherence to treatment. Support from next of kin was associated with a close personal relationship, and it predicted normal total cholesterol. Moreover, physically active respondents perceived receiving higher support from next of kin. Support from nurses was the second strongest predictor of adherence to treatment six years after PCI. Male respondents were more likely to receive a high level of support from nurses. Additionally, normal total cholesterol was associated with higher support from nurses.
Physical activity and male gender were associated with better perceived results of care. Respondents who were in a close personal relationship were more likely take responsibility for their own care. Female gender was more likely associated with lower support from physicians and higher fear of complications. Additionally, respondents with a longer history of CHD had more fear of complications. The binary logistic regression analysis results indicate a statistically significant model for predictors of adherence to treatment. The effect size indicators showed a satisfactory explanatory power with respect to the factors predicting adherence to treatment (Nagelkerke R 2 0.12-0.50) 16, 17 (Table 6 ).
Three-quarters of the respondents (75.2%, n=126) received regular follow-up controls in a primary healthcare, specialised medical care or occupational healthcare setting, which was found to be a statistically significant predictor of better adherence to treatment in multivariate logistic regression (odds ratio 1.10; 95% confidence interval (CI) 1.02-1.19; p=0.01). Additionally, one-third of the respondents (31.5%, n=52) participated in cardiac rehabilitation, which predicted adherence to blood pressure medication (odds ratio 4.35; 95% CI 1.23-15.05; p=0.002). Table 4 . Prevalence of good adherence to treatment and factors known to explain adherence among patients with coronary heart disease (CHD) four months (n=416) and six years after percutaneous coronary intervention (PCI) (n=169).
Mean sum variables
Good adherence % (n) in 2013 Good adherence % (n) in 2019
The mean sum variables related to adherence to treatment Adherence to medication 95. 
Discussion
This study produced new data about the long-term follow-up results of the predicting factors related to adherence to treatment among CHD patients six years after PCI. Similar to the 2013 baseline study, the respondents in the follow-up study reported good adherence to medication in line with Furuya et al. 19 However, numerous previous studies have reported contradictory results, indicating that a substantial number of post-PCI patients exhibit non-adherence to cardiovascular medications. [20] [21] [22] The positive outcome in the present study is significant because failure to adhere to medication is associated with poorer clinical outcomes, higher hospitalisation rates and increased morbidity and mortality among post-PCI patients. 12, 23 Although the respondents' self-reported adherence to a healthy lifestyle and health behaviours were somewhat better in the follow-up study than in the 2013 baseline study, there was a significant conflict between the respondents' health behaviours and secondary prevention guidelines, as also noted by Perk et al., who reported that patients overestimate their adherence to a healthy lifestyle. 15 It the present study, adherence to a healthy lifestyle was significantly Table 6 . Multivariate logistic regression describing the relationship between background variables and mean sum variables known to explain adherence to treatment of patients with coronary heart disease (CHD) after percutaneous coronary intervention (PCI) (n=169).
Predicting factors
Odds ratio (95% CI) higher regarding smoking and alcohol consumption in comparison to the baseline data, but it is still does not met the clinical practice guidelines. 18 Instead, consumption of vegetables was lower in the follow-up study than the baseline study, indicating that only 6.5% of post-PCI patients consume the recommended amount of vegetables (5 dl/ day).
According to the results of the present study, slight improvement in physical activity was seen among the post-PCI patients in comparison to the baseline results. Although the difference was not significantly significant, the level of physical activity was still far from the recommendations of the clinical practice guidelines. Only about 50% of the respondents reported engaging in physical activity at least 120 min per week, as recommended. This is important to note because physical activity is a key factor in managing modifiable CHD risk factors, such as hypercholesterolaemia, hypertension and being overweight. A moderate level of intense physical activity also decreases the risk of premature death and improves cardiorespiratory fitness, cardiac output, muscle strength and endurance, and functional capacity. Additionally, it may improve recovery of physical function after cardiac procedures and enhance health-related quality of life among post-acute myocardial infarction patients; hence, the importance of physical activity should be emphasised in patient education. 18 Respondents that were married or in a close personal relationship received support from next of kin, took responsibility for their own care and were physically more active in comparison to respondents who were unmarried or not in a close personal relationship. Additionally, their blood pressure and cholesterol levels were more likely to be in line with medical guidelines. Previous evidence confirms that support from next of kin is as an important resource for future lifestyle changes among post-PCI patients; 24 it also has a protective effect in maintaining a healthy lifestyle resulting in better overall health status. 25 In nursing science, this means that person-centred care should be the established practice; patients should be involved in their care and next of kin should have the opportunity to participate in caring for patients, if the patients so choose. In contrast, support of patients who do not have a close personal relationship should be ensured and strengthened through other means, such as peer support.
In accordance with our 2013 baseline results, female gender was associated with higher fear of complications six years after PCI. This finding is clinically important because previous studies have indicated a possible connection between fear of complications and activation of the autonomous nervous system, resulting in a lower immune response, impaired heart rate, endothelial dysfunction and vascular inflammation, which could have a negative impact on clinical outcomes. 26 It is disconcerting that, in this study, female gender was associated with lower perceived support from nurses and physicians. On the other hand, this result may indicate gender differences regarding support, as previously reported. 8 Women's higher need for support should be addressed in patient education, in particular, because conventional CHD risk factors, such as smoking, hypertension and dyslipidaemia, have been found to be more harmful to the development and progression of CHD in women than in men. The accumulation of risk factors and the increasing prevalence of hypertension, obesity and diabetes are more common in women than in men. 27 It is interesting to note that, in the 2013 baseline study, support from nurses was not a statistically significant predictor of adherence to treatment, but support from physicians was a significant predictor of females' motivation to adhere. 8 However, six years after PCI, both support from nurses and support from physicians were significant predictors of adherence. This finding highlights the importance of multi-professional collaboration to predict patient adherence, which was also reported by Valaker et al. 21 In the acute phase, after PCI, the therapeutic relationship between patients and their cardiologist is an important predictor for adherence to treatment, 8 and the resources for this should be guaranteed despite the scarce number of cardiologists. This result is in line with Du et al., who confirmed that patient education coordinated by a cardiologist is effective for decreasing cardiovascular risk factors and promoting adherence to treatment. 28 Furthermore, in secondary prevention programmes, nursing interventions are emphasised. In the present study, support from nurses was associated with lower total cholesterol in line with the finding reported in numerous studies that confirmed that nursing interventions had a positive impact on improving patients' health behaviour and managing risk factors. 29, 14 It has been extensively documented that continuum of care in secondary prevention and cardiac rehabilitation do not adhere to recommendations, although their benefits are undeniable. 15, 30 In this study, one-third of the respondents participated in cardiac rehabilitation, and one-third did not have regular follow-up controls. The respondents that received a continuum of care in secondary prevention had better treatment adherence, as also noted by Thomas et al., 30 who reported an association between continuum of care and lower frequency of hospital admissions.
Conclusion
Support from next of kin and nurses, results of care, patient responsibility, support from physicians, fear of complication and continuum of care predicted adherence to treatment in long term. These issues should be emphasised among women, patients without a close relationship, physically inactive patients and those with a longer duration of CHD.
Limitations
The present study has some limitations. First, when using self-reported data collection methods, there is always a risk of the social desirability effect such that patients provide answers they think are favourable instead of saying what they actually believe or sharing information about the actions they actually take. The second limitation relates to the bias associated with the recruitment process in the 2013 baseline study, because, in general, patients are discharged 24 h after PCI. Due to this rapid turnover, there is a risk that patients who met the inclusion criteria for the study were overlooked. Third, it is known that patients who adhere well to treatment are more likely to respond to the questionnaire. Fourth, the results have been analysed, according to the research plan, at the group level which can be limitation also; thus, the generalisability of the results has to be treated with caution. 
Implications for practice
